Latest Information Update: 17 Feb 2016
At a glance
- Originator Fannin Bioscience
- Developer Hefei Anderson Pharma
- Class Antineoplastics; Diterpenes; Drug conjugates; Paclitaxels; Peptides
- Mechanism of Action Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Breast cancer